Arnaud Françoise, Hammett Mike, Asher Ludmila, Philbin Nora, Rice Jennifer, Dong Feng, Pearce Bruce, Flournoy William S, Nicholson Carol, McCarron Richard, Freilich Daniel
Naval Medical Research Center, RMD Hematomimetics Program, Silver Spring, Maryland 20910-7500, USA.
Shock. 2005 Aug;24(2):145-52. doi: 10.1097/01.shk.0000170354.18437.2f.
HBOC-201, a bovine polymerized hemoglobin, has been proposed as a novel oxygen-carrying resuscitative fluid for patients with hemorrhagic shock (HS). Herein, we evaluated the hemostatic effects of HBOC-201 in an animal model of HS. A 40% blood loss-controlled hemorrhage and soft tissue injury were performed in 24 invasively monitored Yucatan mini-pigs. Pigs were resuscitated with HBOC-201 (HBOC) or hydroxyethyl starch (HEX), or were not resuscitated (NON) based on cardiac parameters during a 4-h prehospital phase. Afterward, animals received simulated hospital care for 3 days with blood or saline transfusions. Hemostasis measurements included in vivo bleeding time (BT), thromboelastography (TEG), in vitro bleeding time (platelet function; PFA-CT), prothrombin time (PT), and partial thromboplastin time (PTT). Serum lactate was measured and lung sections were evaluated for microthrombi by electron microscopy. During the prehospital phase, BT remained unchanged in the HBOC group. TEG reaction time increased in HBOC pigs during the late prehospital phase and was greater than in NON or HEX pigs at 24 h (P = 0.03). TEG maximum amplitude was similar for the two fluid-resuscitated groups. PFA-CT increased in both resuscitated groups but less with HBOC (P = 0.02) in the prehospital phase; this effect was reversed by 24 h (P = 0.02). In the hospital phase, PT decreased (P < 0.02), whereas PTT increased above baseline (P < 0.01). Lactic acidosis in HBOC and HEX groups was similar. Aspartate aminotransferase was relatively elevated in the HBOC group at 24 h. Electron microscopy showed no evidence of platelet/fibrin clots or microthrombi in any of the animals. Twenty-four-hour group differences mainly reflected the fact that all HEX animals (8/8) received blood transfusions compared with only one HBOC animal (1/8). In swine with HS, HBOC resuscitation induced less thrombopathy than HEX during the prehospital phase. Mild delayed effects on platelet and clot formation during the hospital phase are transient and likely related to fewer blood transfusions. In swine with HS, HBOC resuscitation induced less thrombopathy than HEX during the prehospital phase but more thrombopathy in the hospital phase. The delayed effects on platelet and clot formation during the hospital phase are transient and may be related to the need for fewer blood transfusions.
HBOC - 201是一种牛源聚合血红蛋白,已被提议作为出血性休克(HS)患者的新型携氧复苏液。在此,我们评估了HBOC - 201在HS动物模型中的止血效果。对24只进行有创监测的尤卡坦小型猪进行40%失血性控制性出血和软组织损伤。在4小时的院前阶段,根据心脏参数,用HBOC - 201(HBOC)或羟乙基淀粉(HEX)对猪进行复苏,或不进行复苏(NON)。之后,动物接受为期3天的模拟医院护理,并进行输血或输注生理盐水。止血测量包括体内出血时间(BT)、血栓弹力图(TEG)、体外出血时间(血小板功能;PFA - CT)、凝血酶原时间(PT)和部分凝血活酶时间(PTT)。测量血清乳酸,并通过电子显微镜评估肺切片中的微血栓。在院前阶段,HBOC组的BT保持不变。在院前后期,HBOC猪的TEG反应时间增加,且在24小时时大于NON组或HEX组(P = 0.03)。两组液体复苏组的TEG最大振幅相似。在院前阶段,两组复苏组的PFA - CT均增加,但HBOC组增加较少(P = 0.02);这种效应在24小时时逆转(P = 0.02)。在医院阶段,PT降低(P < 0.02),而PTT高于基线水平增加(P < 0.01)。HBOC组和HEX组的乳酸酸中毒情况相似。在24小时时,HBOC组的天冬氨酸转氨酶相对升高。电子显微镜检查显示,所有动物均未发现血小板/纤维蛋白凝块或微血栓的证据。24小时的组间差异主要反映了一个事实,即所有HEX组动物(8/8)接受了输血,而HBOC组只有一只动物(1/8)接受了输血。在HS猪中,院前阶段HBOC复苏诱导的血栓形成异常比HEX少。在医院阶段对血小板和凝块形成的轻度延迟影响是短暂的,可能与输血较少有关。在HS猪中,院前阶段HBOC复苏诱导的血栓形成异常比HEX少,但在医院阶段则更多。在医院阶段对血小板和凝块形成的延迟影响是短暂的,可能与输血需求较少有关。